DHQ Flowcharts v2.0
DHQ Flowcharts v2.0
DHQ Flowcharts v2.0
Donor Eligibility: A person should be free of infectious diseases, including colds, on the day of
donation. A person who is not in good health should not donate until it is determined that the
underlying condition is not cause for deferral.
Question #1
No
Yes
Donor Eligibility: The reason the antibiotic was prescribed must be evaluated to determine if
the person has a bacterial infection that could be transmissible by blood. A person with an
infection should not donate.
Question #2
No
Are you currently taking
an antibiotic?
Yes
No
Is diagnosis cause for Accept donor
deferral?
Yes
Defer donor
per SOP Next question
Donor Eligibility: The reason for use of any medication for an infection must be evaluated to
determine if the person has a viral, fungal, parasitic or other infection transmissible by blood. A
person with an infection should not donate.
Question #3
Yes
Is diagnosis cause No
Accept donor
for deferral?
Yes
Defer donor
Next question
per SOP
Donor Eligibility: A person taking medications listed on the Medication Deferral List anytime in
the timeframes indicated is deferred for the appropriate period of time.
Question #4
Have you
taken any medications on No
the Medication Deferral List in Accept donor
the time frames indicated?
Yes
Donor Eligibility: Donors must read the educational materials prior to donating.
Question #5
No
Donor Eligibility: Aspirin irreversibly inactivates platelet function. A person taking aspirin or any
medication containing aspirin should not be the sole source of platelets.
Question #6
Yes
Determine
donation type.
Consult SOP.
Donor Eligibility: A whole blood donor may donate no more frequently than every 8 weeks.
Donors of plasma, platelets or leukocytes by apheresis may donate no more frequently than
every 2 days.
Question #7
Yes
No
Donor Eligibility: Certain vaccinations may contain live infectious agents. A person who has
been exposed to a live infectious agent in a vaccination should not donate for a specified period
of time.
Note on 8alt flowchart: Some blood centers may choose to use a simpler but stricter deferral
scheme in which all donors who received the smallpox vaccination are deferred for a minimum of
56 days, regardless of when the scab fell off. Blood centers using these criteria should use
alternative Flowchart 8alt.
Question #8
In the past 8
weeks, have you had No
Accept donor
any vaccinations or
other shots?
Yes
Next question
Yes
More than 21
When were you days ago? Continue this question
vaccinated for on next page
smallpox?
Fewer than 21
days ago?
No
Yes
No
Donor Eligibility: Certain vaccinations may contain live infectious agents. A person who has
been exposed to a live infectious agent in a vaccination should not donate for a specified period
of time.
Question #8alt.
Yes
Yes
Next question
56 days ago
or more
more
No
Donor Eligibility: Certain vaccinations may contain live infectious agents. A person who has
had close contact with the vaccination site, bandages covering the vaccination site, or materials
that might have come into contact with an unbandaged vaccination site, including clothing, may
be exposed to the live infectious agents and should not donate for a specified period of time
following the contact. See User Brochure Glossary for specifics.
Note on 9alt Flowchart: Some blood centers may choose to use a simpler but stricter deferral
scheme in which all donors who have been in contact with a person who received the smallpox
vaccination are deferred for 56 days if they developed any subsequent complication, skin rash or
sore, regardless of when the rash or sore resolved. Blood centers using these criteria should use
alternative Flowchart 9alt.
Question #9
No
Yes Defer for 3 months
after the date of
Have you the contact’s
No had any severe vaccination;
complication* since if date is not
the time of known, defer for 2
contact? months from
today’s date.
Yes
Has it been 14
Yes
days or more since the
symptoms went
away?
No
*Severe complications include the following: rash (resembling blisters) covering a small or large area of the body; necrosis (tissue
death) in the area of exposure; encephalitis (inflammation of the brain); infection of the cornea (eye); and localized or systemic skin
reaction in someone with eczema or other chronic skin condition.
Donor Eligibility: Certain vaccinations may contain live infectious agents. A person who has
had close contact with the vaccination site, bandages covering the vaccination site or materials
that might have come into contact with an unbandaged vaccination site, including clothing, may
be exposed to the live infectious agent and should not donate for a specified period of time
following the contact. See User Brochure Glossary for specifics.
Question #9alt.
Yes
Yes
*Severe complications include the following: rash (resembling blisters) covering a small or large area of the body;
necrosis (tissue death) in the area of exposure; encephalitis (inflammation of the brain); infection of the cornea (eye);
and localized or systemic skin reaction in someone with eczema or other chronic skin condition.
Donor Eligibility: A donor should not donate double red cells by apheresis more frequently
than every 16 weeks.
Question #10
Yes
Donor Eligibility: A person who has received an allogeneic transfusion of blood, platelets,
plasma or other blood component is at increased risk for transmitting infectious diseases, and is
deferred for 12 months following the transfusion.
Question #11
Yes
Qualify or defer
Next question
donor per SOP
Donor Eligibility: A person who has been exposed to allogeneic tissues through transplant
should not donate blood for 12 months following exposure due to increased risk for transmitting
infectious diseases.
Question #12
Yes
No
Determine if the transplant
was an allogeneic donation.
Yes
Accept donor
Donor Eligibility: A person who has been exposed to allogeneic tissues through grafting should
not donate blood for 12 months following exposure due to increased risk for transmitting
infectious diseases.
Question #13
Yes
Accept donor
Yes
Donor Eligibility: A person who has had one of the following in the past 12 months: 1) contact
with an open wound, non-intact skin or mucous membrane with the blood of a person, or 2) a
needle-stick or other sharps injury from an instrument that has been used on a person, is at
increased risk for transmitting infectious diseases, and is deferred for 12 months from the date of
exposure.
Question #14
Yes
Donor Eligibility: A person who has been exposed to someone else's blood through a needle-
stick is at increased risk for transmitting infectious diseases, and is deferred for 12 months
following the date of exposure.
Question #15
Yes
Yes or
don't know
Donor Eligibility: A person who has had sexual contact with a person with clinical or laboratory
evidence of HIV infection is at increased risk for transmitting HIV and other infectious diseases,
and is deferred for 12 months from the date of last sexual contact. HIV may be transmitted
through sexual contact with an infected person.
Note: Not all donors define "sex" or "sexual contact" in the same way. The donor must have read
the Blood Donor Educational Material provided.
Question #16
Yes
Donor Eligibility: A person who has taken money, drugs, or other payment in exchange for sex
is at increased risk for transmitting HIV and other infectious diseases. The sexual contacts of this
person are also at increased risk for transmitting HIV and other infectious diseases, and are
deferred for 12 months from the date of the last sexual contact. HIV and other diseases may be
transmitted through sexual contact.
Note: Not all donors define "sex" or "sexual contact" in the same way. The donor must have read
the Blood Donor Educational Material provided.
Question #17
Yes
Donor Eligibility: A person who has used needles, in the past or present, to take drugs,
steroids, or anything not prescribed by their doctor is at increased risk for transmitting HIV and
other infectious diseases. The sexual contacts of this person are also at increased risk for
transmitting HIV and other infectious diseases and are deferred for 12 months from the date of
the last sexual contact. HIV and other diseases may be transmitted through sexual contact.
Note: Not all donors define "sex" or "sexual contact" in the same way. The donor must have read
the Blood Donor Educational Material provided.
Note: The phrase "used needles" includes intravenous use, "skin popping" (injection under the
skin), "mainlining" (arterial injection) and any other use of a needle to administer drugs, steroids
or anything else not prescribed by their doctor for intravenous use.
Question #18
Yes
Donor Eligibility: A male who has had sexual contact with another male is at increased risk for
transmitting HIV and other infectious diseases, and is deferred for 12 months from the date of the
last sexual contact with a male. HIV and other diseases may be transmitted through sexual
contact.
Note: Not all donors define "sex" or "sexual contact" in the same way. The donor must have read
the Blood Donor Educational Material provided.
Question #19
Yes
Donor Eligibility: A male who had sexual contact with another male is at increased risk for
transmitting HIV and other infectious diseases. The sexual contacts of the male are also at
increased risk for transmitting HIV and other infectious diseases, and are deferred for 12 months
from the date of the last sexual contact. HIV and other diseases may be transmitted through
sexual contact.
Note: Not all donors define "sex" or "sexual contact" in the same way. The donor must have read
the Blood Donor Educational Material provided.
Question #20
Yes
Defer donor
Next question
Donor Eligibility: A person who has had sexual contact with a person who has viral hepatitis
may be at increased risk for transmitting infection, and is deferred for 12 months from the date of
last contact. Hepatitis, particularly hepatitis B, may be spread through sexual contact.
Note: Not all donors define "sex" or "sexual contact" in the same way. The donor must have read
the Blood Donor Educational Material provided.
Question #21
Yes
viral
asymptomatic hepatitis C
Determine type
Accept donor
of viral hepatitis
hepatitis B,
symptomatic hepatitis C,
or unknown
Donor Eligibility: In certain cases, a person living with someone who has viral hepatitis is at
increased risk for acquiring viral hepatitis as well. A person who is living with a person with viral
hepatitis is deferred for 12 months following the date of the last contact. See User Brochure
Glossary.
Question #22
Yes
Viral
asymptomatic hepatitis C
Determine type
Accept donor
of viral hepatitis
hepatitis B,
symptomatic hepatitis C, or
unknown
Donor Eligibility: A person who has had a tattoo in the past 12 months is deferred for 12
months from the date of the tattoo application, unless applied by a state regulated entity with
sterile needles and non-reused ink. There may be a risk of transmission of infectious diseases
when tattoos have been applied using non-sterile needles and/or reused ink.
Note: Tattoos include tattoo "touch ups", tattoos applied by oneself, and those applied by others.
Question #23
Yes
Qualify or defer
Next question
donor per SOP
Donor Eligibility: A person who has had ear or body piercing during the past 12 months is at
increased risk for transmitting HIV and other infectious diseases, and is deferred for 12 months
from the date of procedure, unless ear or body piercing has been done using single-use
equipment. There is an increased risk for transmitting HIV and other diseases if the equipment is
re-used.
Question #24
Yes
No
Donor Eligibility: A person who has had syphilis or gonorrhea, treatment for either, or a
confirmed reactive screening test for syphilis is at increased risk for transmitting disease, and is
deferred for 12 months after the date treatment is completed.
Question #25
Yes
Yes
Was treatment completed 12 Accept donor
months ago?
No
Donor Eligibility: A person who has been detained or incarcerated in a facility (juvenile
detention, lockup, jail, or prison) for more than 72 consecutive hours (3 days) is at increased risk
for transmitting HIV and other transmissible diseases, and is deferred for 12 months from the last
date of incarceration.
Note: The reason for incarceration (e.g. white-collar crimes, child support) does not change the
deferral
Question #26
Yes
Yes
* In general, residents of a malaria-endemic country will be deferred for 3 years after departure
from the country of residence if they remain free from unexplained symptoms suggestive of
malaria. Prior residents of malaria-endemic countries who live in non-endemic countries for 3
consecutive years without travelling to a malaria-endemic area, will then be deferred for 12
months after subsequent travel to a malaria-endemic area. Prior residents of malaria-endemic
countries who have not lived in non-endemic countries for 3 consecutive years, and then travel to
a malaria-endemic area will be deferred for 3 years after the recent travel to a malaria-endemic
area.
A person who is not a prior resident of malaria-endemic countries and travels to a malaria-
endemic area is deferred for 12 months after departure from that area.
* Note: Use of the definitions (excerpts are provided below) provided in the August 2014 FDA
“Guidance for Industry: Recommendations for Donor Questioning, Deferral, Reentry and Product
Management to Reduce the Risk of Transfusion-Transmitted Malaria” are necessary in order to
use the flowchart properly.
The guidance can be found by date and title on the FDA website at the following link:
http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidanc
es/Blood/default.htm
Definitions
Malaria-endemic area - Any areas with malaria where CDC recommends anti-malarial
chemoprophylaxis in travelers in the most current version of the CDC Health Information
for International Travel (commonly known as The Yellow Book) at the time the donor is
screened.
Malaria-endemic country - Any country having an area or areas with malaria where
CDC recommends anti-malarial chemoprophylaxis in travelers in The Yellow Book at the
time the donor is screened. A country that has any malaria-endemic areas should be
considered to be malaria-endemic in its entirety.
Yes
Only non-endemic
Determine if donor
country(ies)
was in any malaria-
endemic
country(ies)
Malaria-endemic
country(ies)
Only non-
Determine length of ≤5yrs Determine if donor endemic area(s)
stay in malaria- was in any malaria-
endemic country(ies) endemic area(s)
Malaria-endemic
>5 years, area(s)
continuously
>24 hours
Yes
No
No
Donor Eligibility: A person who has spent time that adds up to 3 months or more in the United
Kingdom from 1980 through 1996 is indefinitely deferred. Donors may be at risk of developing
vCJD from eating beef from the United Kingdom are indefinitely deferred. There may be a risk of
transmitting vCJD through blood transfusion.
Question #28
Yes
Defer donor
indefinitely Next question
*See the January 2016 FDA guidance “Revised Preventive Measures to Reduce the Possible Risk of Transmission of
Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products: Guidance for
Industry.”
The guidance can also be found by date and title on the FDA website at the following link:
http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/default.htm
Donor Eligibility: Members of the U.S. military, a civilian military employee, or a dependent of a
member of the U.S. military are indefinitely deferred if they spent a total of 6 months or more
associated with a military base in any of the following countries: From 1980 through 1990 in
Belgium, the Netherlands, or Germany; From 1980 through 1996 in Spain, Portugal, Turkey, Italy
or Greece. These donors may be at risk of developing vCJD from eating beef from the UK and
are indefinitely deferred. There may be a risk of transmitting vCJD through blood transfusion.
Question #29
Yes
Did you
spend a total time of 6
months or more associated
with a military base in any of the
following countries: No
·From 1980 through 1990 in Belgium, the Accept donor
Netherlands, or Germany;
·From 1980 through 1996 in Spain,
Portugal,
Turkey, Italy or Greece?
Yes
Donor Eligibility: A person who spent time that adds up to 5 years or more in Europe from
1980 to the present may be at risk of developing vCJD from eating beef in Europe and is
indefinitely deferred. There may be a risk of transmitting vCJD through blood transfusion.
Question #30
Yes
Defer donor
indefinitely Next question
*See the January 2016 FDA guidance “Revised Preventive Measures to Reduce the Possible Risk of Transmission of
Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products: Guidance for Industry.”
The guidance can also be found by date and title on the FDA website at the following link:
http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/default.htm
Question #31
Yes
Defer donor
Next question
indefinitely
*See the January 2016 FDA guidance “Revised Preventive Measures to Reduce the Possible Risk of Transmission of
Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products: Guidance for Industry.”
The guidance can also be found by date and title on the FDA website at the following link:
http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/default.htm
Donor Eligibility: A female who is pregnant now or was pregnant in the past 6 weeks is
deferred for the safety of the donor. Previous pregnancies are associated with developing
antibodies that can cause TRALI, a serious transfusion complication. Blood centers have SOPs
for donor qualification and testing to reduce this risk of TRALI.
Question #32
(Female donors)
Have
No
you ever been pregnant or are Accept donor
you pregnant now?
Qualify or defer
Pregnant now or in past 6 No
donor per
weeks? TRALI SOP
Yes
Defer donor
Donor Eligibility: A person with clinical or laboratory evidence of HIV/AIDS is at increased risk
for transmitting HIV and other infectious diseases, and is indefinitely deferred.
Question #33
Yes
Donor Eligibility: A person who has used needles, in the past or present, to take drugs,
steroids, or anything not prescribed by their doctor is at increased risk for transmitting HIV and
other infectious diseases, and is indefinitely deferred.
Note: The phrase "used needles" includes intravenous use, "skin popping" (injection under the
skin), "mainlining" (arterial injection) and any other use of a needle to administer drugs, steroids
or anything else not prescribed by their doctor for intravenous use.
Question #34
Yes
Defer donor
Next question
indefinitely
Donor Eligibility: A person who has received money, drugs, or other payment for sex is at
increased risk for HIV and other infectious diseases, and is indefinitely deferred.
Note: Not all donors define "sex" or "sexual contact" in the same way. The donor must have read
the Blood Donor Educational Material provided.
Question #35
Yes
Defer donor
Next question
indefinitely
\Donor Eligibility: A person who has had malaria and received an appropriate treatment is
deferred for three years after becoming asymptomatic while residing in a non-endemic country.
Malaria can be transmitted through blood transfusion.
Question #36
No
Have you ever had malaria?
Yes
No
Donor Eligibility: A person who has had Chagas disease is indefinitely deferred. Chagas disease can
be transmitted by blood.
Question #37
No
Have you ever had
Accept donor
Chagas disease?
Yes
Donor Eligibility: A person who has had babesiosis is indefinitely deferred. Babesiosis can be
transmitted by blood.
Question #38
No
Have you ever had
Accept donor
babesiosis?
Yes
Donor Eligibility: A person who has received an allogeneic dura mater transplant or graft may be at risk
for Creutzfeldt-Jakob disease, and is permanently deferred. Autologous dura mater grafts are acceptable.
*Xenotransplantation definitions are provided in the January 19, 2001 document “PHS Guideline on
Infectious Disease Issues in Xenotransplantation”. The guidance is available at www.fda.gov.
Note: Nonliving biological products or material from nonhuman animals, such as porcine heart valves
and porcine insulin, are not classified as xenotransplantation products for the purposes of this definition.
Question #39
Have you
ever received
a dura mater (or No
brain covering) graft
or
xenotransplantation
product?
Yes
No
Donor Eligibility: A person with a history of cancer must be evaluated to determine their eligibility to
donate.
Question #40
Yes
Is history of No
cancer reason Accept donor
for deferral?
Yes
Donor Eligibility: A person must be free of acute respiratory disease. A person with a history of
diseases of the heart and lungs, including acute lung diseases or colds, must be evaluated.
Question #41
Yes
Yes
Donor Eligibility: A person with hemophilia or related clotting disorder that requires treatment should be
deferred to prevent harm by the large bore needles used during the donation process.
Note: See the December 2015 FDA guidance, “Revised Recommendations for Reducing the Risk of
Human Immunodeficiency Virus Transmission by Blood and Blood Products.” The guidance can also be
found by date and title on the FDA website at the following link:
http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blo
od/default.htm
Question #42
Yes
Is it hemophilia No
or a related clotting disorder
Accept donor
that requires treatment?
Yes
Defer donor
Next question
Indefinitely
Donor Eligibility: A person with a blood relative with Creutzfeldt-Jakob disease is indefinitely deferred
due to the risk of transmission.
Note: If laboratory testing (gene sequencing) shows that the donor does not have a mutation associated
with familial CJD, the donor is eligible. Gene sequencing of the donor is not necessary to demonstrate
that the donor is not at risk for familial CJD. Sequencing of the family member with CJD or the appropriate
parent of the donor, if the CJD-affected family member was a second-degree relative, may be sufficient to
demonstrate that the donor does not have a mutation associated with familial CJD, as stated in the
January 2016 guidance* found on the FDA website under Blood guidances.
Question #43
Yes
Yes
Defer donor
indefinitely Next question
*See the January 2016 FDA guidance “Revised Preventive Measures to Reduce the Possible Risk of Transmission
of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products: Guidance for
Industry.” The guidance can also be found by date and title on the FDA website at the following link:
http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/default.
htm